Biotronik Can't Seek $100M From J&J Over Stents: Judge
German drugmaker Biotronik AG can't seek $100 million in lost profits in a suit claiming a Johnson & Johnson unit breached a supply contract by issuing a bogus CoStar stent recall,...To view the full article, register now.
Already a subscriber? Click here to view full article